Clinical Trial Detail

NCT ID NCT03330821
Title Pevonedistat, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors University of Southern California
Indications

acute myeloid leukemia

Therapies

Cytarabine + Idarubicin + MLN4924

Age Groups: adult senior

No variant requirements are available.